Jessica Gluck

Jessica Gluck is an Assistant Professor in the Department of Textile Engineering, Chemistry and Science at the College of Textiles, North Carolina State University. Her interdisciplinary work bridges textile science with biomedical engineering and regenerative medicine.

Education:

• Postdoctoral Fellowship, University of California, Davis
• Ph.D. in Molecular, Cellular & Integrative Physiology, University of California, Los Angeles (2013)
• M.S. in Biomedical Engineering, University of California, Los Angeles (2008)
• M.S. in Biomedical Textiles, North Carolina State University (2007)
• B.S. in Textile Technology, North Carolina State University (2005)

Her research focuses on Medical Textiles, Nanotechnology, and Nonwovens, particularly in developing functional biomaterials for tissue engineering and wound healing. She designs advanced fibrous scaffolds, hydrogels, and composite structures that interact with biological systems at the cellular level, emphasizing immunomodulation, biocompatibility, and dynamic culture environments.

Her recent publications (2022–2024) demonstrate a strong trend in biomimetic and bioactive textile-based systems, including vascular grafts, electrospun scaffolds with growth factors, conductive nanocomposites, and antiviral textiles. These works span materials science, bioengineering, and clinical translation, often targeting corneal, cardiovascular, and soft tissue regeneration.

Research Groups:

• Faculty Research: Medical Textiles
• Faculty Research: Nanotechnology
• Faculty Research: Nonwovens
• Academics: Textile Engineering, Chemistry and Science
• Academics: Textile Technology

Dr. Gluck actively mentors students and leads research projects in advanced medical textile development. She has secured research funding (implied by active lab output) and collaborates across disciplines to innovate in healthcare solutions using engineered textiles. Her lab explores next-generation materials for regenerative medicine, including smart scaffolds, controlled drug delivery systems, and standardized testing for antiviral efficacy.